Ellipsiz Ltd

SGX:BIX Stock Report

Market Cap: S$26.1m

Ellipsiz Balance Sheet Health

Financial Health criteria checks 6/6

Ellipsiz has a total shareholder equity of SGD109.7M and total debt of SGD0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SGD126.0M and SGD16.2M respectively.

Key information

0%

Debt to equity ratio

S$0

Debt

Interest coverage ration/a
CashS$54.87m
EquityS$109.74m
Total liabilitiesS$16.23m
Total assetsS$125.97m

Recent financial health updates

No updates

Recent updates

Ellipsiz Ltd's (SGX:BIX) Shares May Have Run Too Fast Too Soon

Aug 28
Ellipsiz Ltd's (SGX:BIX) Shares May Have Run Too Fast Too Soon

Risks To Shareholder Returns Are Elevated At These Prices For Ellipsiz Ltd (SGX:BIX)

Jan 26
Risks To Shareholder Returns Are Elevated At These Prices For Ellipsiz Ltd (SGX:BIX)

Here's Why We Think Ellipsiz (SGX:BIX) Is Well Worth Watching

Jun 27
Here's Why We Think Ellipsiz (SGX:BIX) Is Well Worth Watching

Ellipsiz's (SGX:BIX) Shareholders Have More To Worry About Than Only Soft Earnings

Sep 06
Ellipsiz's (SGX:BIX) Shareholders Have More To Worry About Than Only Soft Earnings

Estimating The Fair Value Of Ellipsiz Ltd (SGX:BIX)

Feb 10
Estimating The Fair Value Of Ellipsiz Ltd (SGX:BIX)

Shareholders May Be More Conservative With Ellipsiz Ltd's (SGX:BIX) CEO Compensation For Now

Oct 15
Shareholders May Be More Conservative With Ellipsiz Ltd's (SGX:BIX) CEO Compensation For Now

Financial Position Analysis

Short Term Liabilities: BIX's short term assets (SGD70.4M) exceed its short term liabilities (SGD15.3M).

Long Term Liabilities: BIX's short term assets (SGD70.4M) exceed its long term liabilities (SGD885.0K).

Debt to Equity History and Analysis

Debt Level: BIX is debt free.

Reducing Debt: BIX had no debt 5 years ago.

Debt Coverage: BIX has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: BIX has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ellipsiz Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geraldine EuMaybank Research Pte. Ltd.